Cargando…
Author Correction: Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017404/ https://www.ncbi.nlm.nih.gov/pubmed/35440617 http://dx.doi.org/10.1038/s41598-022-10890-w |
| _version_ | 1784688753248305152 |
|---|---|
| author | Bai, Xiyuan Buckle, Ashley M. Vladar, Eszter K. Janoff, Edward N. Khare, Reeti Ordway, Diane Beckham, David Fornis, Lorelenn B. Majluf-Cruz, Abraham Fugit, Randolph V. Freed, Brian M. Kim, Soohyun Sandhaus, Robert A. Chan, Edward D. |
| author_facet | Bai, Xiyuan Buckle, Ashley M. Vladar, Eszter K. Janoff, Edward N. Khare, Reeti Ordway, Diane Beckham, David Fornis, Lorelenn B. Majluf-Cruz, Abraham Fugit, Randolph V. Freed, Brian M. Kim, Soohyun Sandhaus, Robert A. Chan, Edward D. |
| author_sort | Bai, Xiyuan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9017404 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90174042022-04-19 Author Correction: Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19 Bai, Xiyuan Buckle, Ashley M. Vladar, Eszter K. Janoff, Edward N. Khare, Reeti Ordway, Diane Beckham, David Fornis, Lorelenn B. Majluf-Cruz, Abraham Fugit, Randolph V. Freed, Brian M. Kim, Soohyun Sandhaus, Robert A. Chan, Edward D. Sci Rep Author Correction Nature Publishing Group UK 2022-04-19 /pmc/articles/PMC9017404/ /pubmed/35440617 http://dx.doi.org/10.1038/s41598-022-10890-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Author Correction Bai, Xiyuan Buckle, Ashley M. Vladar, Eszter K. Janoff, Edward N. Khare, Reeti Ordway, Diane Beckham, David Fornis, Lorelenn B. Majluf-Cruz, Abraham Fugit, Randolph V. Freed, Brian M. Kim, Soohyun Sandhaus, Robert A. Chan, Edward D. Author Correction: Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19 |
| title | Author Correction: Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19 |
| title_full | Author Correction: Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19 |
| title_fullStr | Author Correction: Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19 |
| title_full_unstemmed | Author Correction: Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19 |
| title_short | Author Correction: Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19 |
| title_sort | author correction: enoxaparin augments alpha-1-antitrypsin inhibition of tmprss2, a promising drug combination against covid-19 |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017404/ https://www.ncbi.nlm.nih.gov/pubmed/35440617 http://dx.doi.org/10.1038/s41598-022-10890-w |
| work_keys_str_mv | AT baixiyuan authorcorrectionenoxaparinaugmentsalpha1antitrypsininhibitionoftmprss2apromisingdrugcombinationagainstcovid19 AT buckleashleym authorcorrectionenoxaparinaugmentsalpha1antitrypsininhibitionoftmprss2apromisingdrugcombinationagainstcovid19 AT vladareszterk authorcorrectionenoxaparinaugmentsalpha1antitrypsininhibitionoftmprss2apromisingdrugcombinationagainstcovid19 AT janoffedwardn authorcorrectionenoxaparinaugmentsalpha1antitrypsininhibitionoftmprss2apromisingdrugcombinationagainstcovid19 AT kharereeti authorcorrectionenoxaparinaugmentsalpha1antitrypsininhibitionoftmprss2apromisingdrugcombinationagainstcovid19 AT ordwaydiane authorcorrectionenoxaparinaugmentsalpha1antitrypsininhibitionoftmprss2apromisingdrugcombinationagainstcovid19 AT beckhamdavid authorcorrectionenoxaparinaugmentsalpha1antitrypsininhibitionoftmprss2apromisingdrugcombinationagainstcovid19 AT fornislorelennb authorcorrectionenoxaparinaugmentsalpha1antitrypsininhibitionoftmprss2apromisingdrugcombinationagainstcovid19 AT majlufcruzabraham authorcorrectionenoxaparinaugmentsalpha1antitrypsininhibitionoftmprss2apromisingdrugcombinationagainstcovid19 AT fugitrandolphv authorcorrectionenoxaparinaugmentsalpha1antitrypsininhibitionoftmprss2apromisingdrugcombinationagainstcovid19 AT freedbrianm authorcorrectionenoxaparinaugmentsalpha1antitrypsininhibitionoftmprss2apromisingdrugcombinationagainstcovid19 AT kimsoohyun authorcorrectionenoxaparinaugmentsalpha1antitrypsininhibitionoftmprss2apromisingdrugcombinationagainstcovid19 AT sandhausroberta authorcorrectionenoxaparinaugmentsalpha1antitrypsininhibitionoftmprss2apromisingdrugcombinationagainstcovid19 AT chanedwardd authorcorrectionenoxaparinaugmentsalpha1antitrypsininhibitionoftmprss2apromisingdrugcombinationagainstcovid19 |